GPCR

Structure Therapeutics Inc. (GPCR) is a clinical-stage biopharmaceutical company based in South San Francisco, California, dedicated to developing innovative oral therapeutics for chronic diseases with substantial unmet medical needs. The company boasts a promising pipeline of drug candidates, leveraging advanced scientific methodologies and a robust patient-centric focus to create effective treatment solutions. With its commitment to improving patient outcomes, Structure Therapeutics is well-positioned to attract institutional investors interested in transformative healthcare advancements within the biopharmaceutical sector.